Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P56851 (
epididymal
)
11,273
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Transgenic male C57BL/6 lambda/lacI mice were used to assess the mutagenic response in seminiferous tubules and
epididymal
spermatozoa 3 days after exposure to ethylnitrosourea (ENU), iso-
propyl methanesulfonate
(iPMS) and methyl methanesulfonate (MMS). No significant mutagenic response was observed in
epididymal
spermatozoa for all three compounds, as expected 3 days after treatment. However, ENU and iPMS treated samples demonstrated significant mutagenic inductions relative to controls in seminiferous tubules while MMS treated samples did not. The failure of MMS to induce a mutagenic response in lambda/lacI transgenic mice is likely due to a combination of the low dose used, the short expression time after exposure and the reduced sensitivity to large deletion events in transgenic lambda/lacI shuttle vectors. In addition, ex vivo mutations were measured in control samples and iPMS treated samples, where 33% of mutants from control samples and 35% of mutants from iPMS treated samples were mosaic.
...
PMID:Evaluation of the transgenic Lambda/LacI mouse model as a short-term predictor of heritable risk. 905 73